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Abstract 
The development of peptides as catalysts for preparing optically active molecules is 
an ongoing investigation.  Efforts at expanding the use of peptides are explored in two ways: 
investigating novel reactions in which peptides can act as asymmetric catalysts and through 
expanding the substrate scope of peptides in performing kinetic resolutions. 
Attempts at furthering the reaction scope of acylsulfonamide-containing peptides to 
act as BrØnsted acids through promoting the attack of 7-methyl oct-6-ene-1-tosylaziridine (9) 
by an internal π-nucleophile are discussed herein.  Also reported is the use of pentameric 
peptides containing a π(-methyl)histidine residue in the kinetic resolution of the primary 
alcohol 4-hydroxymethyl cyclopent-2-enone (76) and the secondary aliphatic alcohol 2-
pentanol.  Moderate selectivities were observed in the kinetic resolution of 4-hydroxymethyl 
cyclopent-2-enone (76) and promising results were obtained in the initial screening of 
catalysts for the resolution of 2-pentanol. 
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Introduction 
Molecular recognition is a powerful concept in organic chemistry.  The idea of non-
covalent interactions is not new and is at the heart of many chemical interactions, especially 
between a catalyst and substrate.  Understanding and utilizing these interactions provides a 
great and yet unmet challenge in the development of organic chemistry.  While there is a 
considerable amount known about the different types of interactions concerning both 
attractive forces such as hydrogen bonding or repulsive forces such as electrostatic repulsion, 
harnessing the power of such effects is still a developing concept.1  Designing and 
implementing organocatalysts is arguably one of the most interesting applications implied in 
studying non-covalent interactions.  Progress in this area has been staggering in recent years, 
leading to a plethora of reactions in which organocatalysis can now be implemented.2   
 Using some of the fundamentals of molecular recognition, the Miller laboratory has 
developed peptide catalysts that perform a variety of reactions, including asymmetric 
phosphorylation and acylation.  These peptide catalysts have successfully demonstrated 
effectiveness in performing kinetic resolutions of several secondary and tertiary alcohols 
along with the desymmetrization of a primary diol.  It is thought that hydrogen bonding 
contributes to the selectivity of these reactions in two ways: (1) by controlling the peptide 
secondary structure; and (2) through stabilizing interactions between the catalyst and 
substrate.3  
                                                
1 (a) For a compendium of reviews on molecular recognition see: Chem. Rev. 1997, 97. (b) 
Gellman, S. H. Chem. Rev., 1997, 97, 1231-1232. 
2 Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138-5175. (b) Dalko, P. I.; 
Moisan, L. Angew. Chem. Int. Ed. 2001, 40, 3726-3748. 
3 Jarvo, E. R.; Copeland, G. T.; Papaioannou, N.; Bonitatebus, P. J.  Jr.; Miller, S. J. J. Am. 
Chem. Soc. 1999, 121, 11638-11643. 
  v     
 Expanding the use of peptides as enantioselective catalysts is an ongoing effort.  
Experiments dealing with the diversification of the reaction and substrate scope for peptides 
in preparing optically active compounds are reported herein.  Research was focused on 
performing kinetic resolutions of the primary alcohol 4-hydroxymethyl cylclopent-2-enone 
(76) and the aliphatic secondary alcohol 2-pentanol.  In addition, attempts at utilizing 
peptides containing acylsulfonamides as BrØnsted acid catalysts were also investigated in 
promoting the nucleophilic attack on a p-tolunesulfonyl protected aziridine 9 from an internal 
π-nucleophile.  
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Chapter 1: π-Nucleophilic Attack on Aziridines Promoted by BrØnsted Acids 
 
1.1 BrØnsted Acids as Organocatalysts 
The ability of BrØnsted acids to perform as organic catalysts has been historically 
well documented; however, until recently they have generally been underutilized in organic 
synthesis.4  BrØnsted acids as asymmetric catalysts have been largely overshadowed by 
Lewis acids for a variety of reasons, including the capability of “tuning” steric and electronic 
characteristics around a metal center by adjusting attached ligands or counter ions.  Another 
disadvantage associated with BrØnsted acid catalysis is the lack of directionality associated 
with the hydrogen atom’s s orbital.5 Despite initial prejudice towards BrØnsted acids their 
utility as asymmetric catalysts has reemerged as an area of increased interest.  The use of 
BrØnsted acids as catalysts has recently been reported for a variety of transformations 
including the Diels-Alder reaction, Michael additions, the Strecker reaction, the Morita 
Baylis-Hillman reaction, and in the hydrogenation of imines.6 
Jacobsen applied thiourea based catalysts to the asymmetric Strecker reaction in his 
seminal work on BrØnsted acids as organocatalysts.7  In an investigation involving thioureas 
                                                
4 (a) Babine, R. E.; Bender, S. L. Chem. Rev. 1997, 97, 1359-1472. (b) Schmidtchen, F. P.; 
Berger, M. Chem. Rev. 1997, 97, 1609-1646. 
5 (a) Taylor M. S.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520-1543. (b) Connon, 
S. J. Angew. Chem. Int. Ed. 2006, 45, 3909-3912. 
6 For examples see: (a) Schreiner, P. R.; Wittkopp, Org. Lett. 2002, 4, 217-220. (b) Rueping, 
M.; Azap, C.; Sugiono, E.; Theissmann, T. Synlett 2005, 15, 2367-2369. (c) Schuster, T.; 
Bauch, M.; Durner, G.; Gobel, M. W. Org. Lett. 2000, 2, 179-181. (d) Huang, Y.; Unni, A. 
K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146. (e) Okino, T.; Hoashi, Y.; 
Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 12672-12673. 
7 (a) Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 5315-5316. (b) Sigman, 
M. S.; Vachal, P.; Jacobsen E. N. Angew. Chem. Int. Ed. 2000, 39, 1279-1281. (c) Vachal, P.; 
Jacobsen, E. N. Org. Lett. 2000, 2, 867-870. (d) Vachal, P.; Jacobsen, E. N. J. Am. Chem. 
Soc. 2002, 124, 10012-10014. 
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as ligands for metal catalyst control, experiments revealed that the ligand was a competent 
catalyst for the addition of cyanide to imine substrates.  A detailed investigation into the 
mechanism of this reaction indicates a hydrogen bond interaction between thiourea catalyst 2 
and imine 1 (Scheme 1).  This hydrogen bond is thought to activate the imine towards 
nucleophilic attack from cyanide.  Additionally the hydrogen bond likely influences the 
selective outcome of this reaction by helping to maintain a rigid transition state.  Although all 
of the details of this mechanism are not fully elucidated, the Jacobsen group has 
demonstrated that this catalyst can be applied to a variety of substrates, resulting in excellent 
selectivity and yields (Scheme 1).  
R1 R2
N R3
HCN
Me
N
O
N
H
N
H
StBu
N
HO
tBu OCOtBu
R1 CN
HN
R2
R3
R1=aryl or alkyl, R2=H or Me
R3=aryl, alkyl, heteroatom
85-99% yield
70-99% ee
Scheme 1: Asymmetric Strecker reaction using Jacobsen's thiourea catalsyt
1.1 mol % cat. 2
toluene, -78 oC
Catalyst 2
1 3
Me
 
Investigation into novel methods for catalyzing regiospecific glycosylation reactions 
led to initial interest in BrØnsted acids as catalysts.  Through activation of sugar 5, and 
presumably oxonium ion formation, partial selectivity is observed relating to formation of α 
to β anomers.8  Using the achiral BrØnsted acid catalyst picric acid, this reaction results in a 
3:2 ratio of the α to β anomers.  With the use of acylsulfonamide catalyst 2 a 2:3 ratio of 
products is observed, with the opposite anomer being the major product (Scheme 2).  
                                                
8 Griswold, K. S.; Horstmann, T. E.; Miller, S. J. Synlett 2003, 12, 1923-1926. 
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OBnCatalyst (10 mol%)
CH2Cl2
4 A M. S.
25 oC
Scheme 2: Acid activation of trichloroacetimidate
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S
N
H
O O O
N
O
OMe
Cat. Reaction
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(%)
7A
7B
43
24
60
80
40:60
40:60
4 5 6
catalyst 7  
A: R=CH3
B: R=Cl
picric acid 1.5 Quant. 60:40
 
In an effort to examine the prowess of acylsulfonamides as BrØnsted acids, an 
investigation focused on the activation of aziridines towards intramolecular attack from π-
nucleophiles was undertaken.   To study this possibility it was decided to focus on the 
cyclization of 7-methyl octa-6-ene-1-tosylaziridine (8).  It was envisaged that a BrØnsted acid 
catalyst could be utilized to promote the cyclization of aziridine 8, resulting in the formation 
of three distinct products (Scheme 3).  Further, utilizing a chiral BrØnsted acid would open 
the possibility of selectively controlling the product ratio and provide a means to obtain 
optically active products by way of a kinetic resolution of the racemic starting material.  
NTs
N Ts
NHTs
Scheme 3: Cyclization of 7-methyl oct-6-ene-1-tosylaziridine (8)
8 9 10
NHTs
11  
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1.2 Aziridines in Organic Chemistry 
Aziridines possess unique and fascinating reactivity due to a high ring strain energy of 
27-28 kcal mol-1.  This ring strain is mostly a result of restricted bond angles (60o) necessary 
for the formation of a three-membered ring.  Chemists have taken advantage of this reactivity 
and by utilizing aziridines in a variety of different situations: as intermediates in the synthesis 
of small molecules, chiral auxilaries for controlling selectivity and as monomeric units in the 
formation of polymers. 9  
The strain associated with a three-membered ring leaves aziridines susceptible 
towards attack from a variety of nucleophiles including nitrogens, oxygens, phosphines and 
carbons (Scheme 4a).10  Activation of aziridines can also be achieved through ring opening, 
with stabilization of the resulting 1,3 dipole, allowing formal [3+2] cycloaddition reactions to 
occur with a variety of olefins (Scheme 4b).11  Reduction of aziridines via a one electron 
transfer process using samarium iodide has allowed for the synthesis of a variety of β-amino 
ketones (Scheme 4c).12  Aziridines also present themselves as precursors in chemical 
synthesis that can readily undergo ring expansion, giving a variety of products, including β-
lactams (Scheme 4d).13,14 
                                                
9 For a comprehensive review on Aziridines see: Pearson, W. H.; Lian, B. N.; Bergmeier, S. 
C. Comprehensive Heterocyclic Chemistry II, ed. A. R. Katritzky, C. W. Ress, E. F. Scriven 
and A. Padwa, Pergamon, Oxford, 1996, Vol. 1A, p. 1-60. 
10 Wakamiya, T.; Shimbo, K.; Shiba, T.; Nakajima, K.; Neya, M.; Okawa, K. Bull. Chem. 
Soc. Jpn. 1982, 55, 3878-3881. 
11 Garner, P.; Dogan, O.; Youngs, W. J.; Kennedy, V. O.; Protasiewicz, J.; Zaniewsjki, R. 
Tetrahedron 2001, 57, 71-85. 
12 (a) Molander, G. A.; Stengel, P. J. J. Org. Chem. 1995, 36, 8431. (b) Molander, G. A.; 
Stengel, P. J. Tetrahedron 1997, 53, 8887-8912. 
13 (a) Fugami, K.; Miura, K.; Morizawa, Y.; Oshima, K.; Utimoto, K.; Nozaki, H. 
Tetrahedron 1989, 45, 3089-3098. (b) Spears, G. W.; Nakanishi, K.; Ohfune, Y. Synlett 
1991, 91-92 (c) Chamchaang, W.; Pinhas, A. R. J. Org. Chem. 1990, 55, 2943-2950. 
14 Tanner, D. Angew. Chem. Int. Ed. Engl. 1994, 33, 599-619. 
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Scheme 4: Reactions of aziridines
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N
Me
Ts
N
Ts
[Pd(PPh3)4]
98 % yield
N
OBn
Boc
Pdo, CO
51 % yield
NH
O
OBn
D: Ring expansion of aziridines
22 23 24 25
 
Protected nitrogens in aziridines show different physical characteristics than aliphatic 
nitrogens.  Due to the strain associated with aziridines, more sp3 character at the nitrogen is 
observed, instead of the expected sp2 character of a sulfonamide.  Because of this skewed 
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hybridization, the orbital containing the lone pair of electrons on the nitrogen possesses more 
S character than would be expected.  As a result of the nitrogen’s lone pair’s greater S 
character, carbonyl or sulfonyl protecting groups contain less iminium character than 
observed in less strained systems.15   
N
X
R
O R1
N
X
R
O R1
Figure 1: reactivity of Aziridines
favored disfavored
A) Resonance of aziridines
N
R H
+
N
R
H
Nuc-
N
H
NucR
B.) Protonation of Aziridines
 
 
1.3 π-Nucleophilic Attack on Aziridine Rings: Previous Examples 
 Reactivity of azridines towards nucleophilic attack provides interesting avenues for 
organic synthesis.  Exploiting this reactivity provides novel methodology in the production of 
optically active synthetic intermediates.  While it is necessary to establish the stereochemistry 
in the initial preparation of the aziridine ring to achieve optically active products, there are 
still issues of regioselectivity that merit consideration in the nucleophilic attack of aziridines.  
Of particular interest is the ability of π-based nucleophiles to attack aziridines, resulting in a 
new carbon-carbon bond, or substituted ring systems in the case of an internal π-nucleophile. 
Early examples of π-nucleophilic attack on aziridines employ the use of Lewis acid 
catalysts with indole or pyrrole as the π-nucleophile. 16  An example of this work includes the 
                                                
15 McCoull, W.; Davis, F. A. Synthesis 2000, 10, 1347-1365. 
16 (a) Nishikawa, T.; Kajii, S.; Wada, K.; Ishikawa, M.; Isobe, M. Synthesis 2002, 12, 1658-
1662. (b) Sato, K.; Kozikowski, A. P. Tetrahedron Lett. 1989, 30, 4073-4076. 
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12 
use of scandium triflate to prepare tryptophan derivatives 28 (Scheme 5A).17  Similarly, 
indium tribromide has been shown to be as an effective Lewis acid in activating aziridines 
towards the attack from pyrrole 30 (Scheme 5B).18 
N
H
Me
MeO
N
Cbz
O
O
Sc(OTf)3
CH2Cl2
O
O
NHCbzHN
H
Me
MeO
Scheme 5: Lewis acid activation of aziridines
A: Preparation of tryptophan analogs
N
HAr
Ts
N
InBr3
CH2Cl2, r.t. NH Ar
NHTs
B: Indium promoted attack of aziridines by pyrrole
26 27 28
29 30 31  
Aziridines also participate in formal [3+2] cycloadditions.  These cyclizations have 
been reported to be catalyzed by a variety of Lewis acids.  As demonstrated by Ungureanu et 
al., treatment of aziridine 29 with scandium triflate in the presence of furan 32 leads to 
bicyclic products 33a and 33b (Scheme 6).19  
Scheme 6: Formal [3+2] cycloaddition of aziridines and alkenes
N
Ts
Ar
O
Sc(OTf)3
CH2Cl2
ON
Ts
H
H
ON
Ts
H
H
Ar Ar
29 32 33a 33b   
                                                
 17 Bennani, Y. L.; Zhu, G.-D.; Freeman, J. C. Synlett 1998, 754-756. 
18 (a) Yadav, J. S.; Reddy, B. V. S.; Parimala, G Synlett 2002, 1143-1145. (b) Yadav, J. S.; 
Reddy, B. V. S.; Abraham, S.; Sabitha, G. Tetrahedron Lett. 2002, 43, 1565-1567. 
19 (a) Ungureanu, I.; Bologa, C.; Chayer, S.; Mann, A. Tetrahedron Lett. 1999, 40, 5315-
5318. (b) Yadav, J. S.; Reddy, B. V. S.; Pandey, S. K.; Srihari, P.; Prathap, I. Tetrahedron 
Lett. 2001, 42, 9089-9092. 
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In 1999, Bergmeier et al. demonstrated the importance that the stoichiometry of the 
Lewis acid plays on the reaction outcome.  Treatment of aziridine 34 with a catalytic amount 
of BF3•OEt2 gave bicyclic pyrrolidine product 35, resulting from a formal [3+2] cyclization 
between the 1,3-dipole and the olefin.  When that same aziridine is subjected to a 
superstoichiometric amount of BF3•OEt2, the monocyclic product resulting form the π-
nucleophilic attack of the alkene is observed (Scheme 7). While this is an intriguing outcome, 
there is no explanation offered as to the alteration of the reaction mechanism resulting from 
the differing amounts of Lewis acid used.20 
Scheme 7: Effects of Lewis acid stoichiometry
TsN
SiR3
NHTs
300 mol %
NTs
SiR3
15 mol %
35 34 36
BF3 OEt2BF3 OEt2
 
 
1.4 Preparation of 7-Methyl oct-6-ene-1-tosylaziridine (8) 
Preliminary attention to the preparation of 7-methyl oct-6-ene-1-tosylaziridine (8)  
focused on the preparation of 2-(5-methylhex-4-enyl)oxirane (39) as a synthetic precursor.  
With this strategy in mind, epoxidation of 7-methylocta-1,6-diene (37) was attempted.  
Treatment of diene 37 with m-CPBA gave exclusively the more substituted epoxide 38 
(Scheme 8).  This outcome can be rationalized, as the higher substitution of the tertiary olefin 
increases its electron density, therefore increasing its reactivity towards the electrophilic 
epoxidation reagent.  
                                                
20 Bergmeier, S. C.; Fundy, S. L.; Seth, P. P. Tetrahedron 1999, 55, 8025-8038. 
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OO
Scheme 8: Epoxidation of 7-methylocta-1,6-diene
37 38 39  
The second-generation method started with ozonolysis of cyclopentene 40, using the 
protocol developed by Schreiber and coworkers, affording dimethyl acetal 41.21  Wittig 
olefination of the resulting aldehyde then gave the desired substituted olefin 42.  It was then 
envisaged that cleavage of dimethyl acetal 41 with acid would afford the desired aldehyde, 
which could be treated with dimethyl sulfoxide under Corey-Chaykovsky conditions giving 
terminal epoxide 44 (Scheme 9).22  Unfortunately, the volatility of aldehyde 41 coupled with 
low yields of the Wittig olefination resulted in poor yields for olefin 42.  
H OMe
O OMe
OMe
OMe
O
1) O3, -78 
oC
2) TsOH, Me2S
MeOH, -78 oC
n-BuLi, THF
0 oC          rt
PPh3
Br
13 % Yield
NTs 1) Acid
2) NaH,
S
O
MN3, PPh3
Scheme 9: Initial attempt at the preparation of the aziridine
40 41 42
398  
The preparation of 7-methyl oct-6-ene-1-tosylaziridine (8) was achieved using a five-
step synthesis, starting from racemic allyl glycine 43. This procedure, originally reported by 
                                                
21 (a) Claus, R. E.; Schreiber, S. L. Org. Synth. 1986, 64, 150-155. (b) Schreiber, S. L.; Kelly, 
S. E.; Porco, J. A. Jr.; Sammakia, T.; Suh, E. M. J. Am. Chem. Soc. 1988, 110, 6210-6218. 
22 (a) Corey, E. J.; Chaykovsky, M. J. Am. Chem. Soc. 1962, 84, 866-867. (b) Gololobov, Y. 
G.; Nesmeyanov, A. N.; Lysenko, V. P.; Boldeskul, I. E. Tetrahedron 1987, 43, 2609-2651. 
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Bergmeierer et al., starts with the formation of tosyl amide 44.23  Reduction of the methyl 
ester 44 with lithium aluminum hydride (LiAlH4) gives the desired amino alcohol 45. 
Subjection of 45 to Mitsunobu conditions (diethyl azodicarboxylate (DEAD) and triphenyl 
phosphine (PPh3)), allows for cyclization giving aziridine 46 in 53% yield.  Finally a β-alkyl 
Suzuki reaction was used to install the desired olefin, giving the final product in five steps 
(Scheme 10).  
NH2
OH
O
1) HCl, MeOH
NHTs
OMe
O
2) Et3N, TsCl 
CH2Cl2
LiAlH4, THF
 DEAD, PPh3, 
THFNTsNTs
OH
NHTs
1) 9-BBN, THF
2)PdCl2(dppf)
K3PO4, DMF, A
A= Br
87% yield
57 % yield
58 % 2 steps
20 % yield
Scheme 10: Preparation of aziridine substrate
43 44 45
468
 
The first two steps of this synthesis proceeded cleanly giving pure material in 
excellent yields.  However, trouble was encountered when reducing methyl ester 44.  
Following literature precedent, sodium borohydride (NaBH4) was originally utilized as the 
reducing agent, leading to only a moderate yield.  To increase the efficiency of this reaction, 
a variety of reducing agents and work up procedures were examined.  Lithium aluminum 
hydride (LiAlH4) was found to be the most efficient reducing agent.  A large boost in yield 
                                                
23 Lapinsky, D. J.; Bergmeier, S. C. Tetrahedron Lett. 2001, 42, 8583-8586. 
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was also obsereved by altering the work up protocol to involve the addition of water, then 3 
molar HCl, followed by more water.24 
 
1.5 Results and Discussion 
Treatment of 7-methyl oct-6-ene-1-tosylaziridine (8) with BF3•OEt2, following 
literature precedent, gave the expected bicyclic pyrrolidine product 9 (Scheme 11).  This 
product was observed as a single diastereomer; however, attempts at elucidating the relative 
stereochemistry of this product with COSY NMR experiments resulted in no conclusive 
evidence as to the ring stereochemistry.  Due to the large ring strain associated with trans-
fused bicyclic pyrrolidine rings, it is assumed that the product results from a cis-fused bicyclic 
pyrrolidine ring. 
NTs
NTs
NTs
H
H
Through bond 
interatction expected
Cis-fused bicyclic system
Scheme 11: Treatment of Aziridine 8 with BF3 OEt2
CH2Cl2, 5 h, rt
(15 mol %)
BF3 OEt2
8 9  
Efforts at probing the reactivity of aziridine 8 with a variety of BrØnsted acids leads to 
the conclusion that a strong acid is necessary to invoke cyclization.  Preliminary acids chosen 
for this study involved catechol, 4,5-dicyanoimidazole, acetic acid, and trifluoroacetic acid 
(Table 1).  These acids were chosen to give a range of pKa’s and were tested in both 
stoichiometric and substoichiometric amounts.  Monitoring of each reaction was done using 
thin layer chromatography and each reaction was run at room temperature.  From this initial 
                                                
24 Oi, R.; Sharpless, K. B. Org. Synth. 1998, 9, 251-257. 
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study the only acid effective in cyclizing aziridine 8 was trifluoroacetic acid, giving three 
distinct products.  
S NHO
O
O
N
O NH
Acid ReactionpKa
OH
O
F3C OH
O
OH
OH
H
N
N
NC
NC
3 products
No Reaction
No Reaction
No Reaction
No Reaction
-0.25
 4.76
9.48
5
6-7
NTs
NHTs
Acid (1 eq.)
CH2Cl2, 24 h, rt
Table 1: Activation of aziridine by Br!nsted Acid
8 10
entry
1
2
3
4
5
 
1.6 Conclusion 
As expected from the outcome of previous experiments, treatment of aziridne 8 with 
both catalytic and stoichiometric amounts of acyl sulfonamide catalyst gave no reaction.  This 
preliminary data indicates that the strength of the acid needed to invoke cyclization is beyond 
that which acyl sulfonamide provides.  Initial limits of the reaction have been identified as 
being outside the realm of our current technology using peptide catalysis. Strengthening the 
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acidity associated with acyl sulfonamide by replacing the toluene methyl with a chlorine or a 
nitro group is a potential solution to this problem.  Work involving the use of strong acids in 
peptides would present some fascinating questions and is an area worthy of further 
investigation. 
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1.7 Experimental 
General methods: 
 1H NMR spectra were recorded on Varian 400 or 300 spectrometers.  Proton chemical 
shifts are reported in ppm (δ) relative to internal tetramethylsilane (TMS, δ 0.0) or with 
solvent reference relative to TMS employed as the internal standard (CDCl3, δ 7.26 ppm; 
D2O, d).  Data are reported as follows: chemical shift (multiplicity [singlet (s), doublet (d), 
triplet (t), quartet (q), and multiplet (m)], coupling constants [Hz], integration), 13C NMR 
spectra were recorded on Varian 400 (100 MHz) or 300 (75 MHz) spectrometers with 
complete proton decoupling.  Carbon chemical shifts are reported in ppm (δ) relative to TMS 
with the respective solvent resonance as the internal standard (CDCl3, δ 77.0).  NMR data 
were collected at ambient temperature, unless otherwise indicated.  In cases where more than 
one conformation for a given compound is observed at the indicated temperature, the data for 
the major conformer are reported.  Analytical thin-layer chromatography (TLC) was 
preformed using Silica Gel 60 F254 precoated plates (0.25 mm thickness).  Visualization was 
accomplished by irradiation with UV lamp and/or staining with KMnO4 or Cerium 
ammonium molybdate (CAM) solutions.  Flash column chromatography was preformed 
using Silica Gel 60A (170-400 mesh) from Fisher Scientific.25  Mass spectra were obtained at 
the Mass Spectrometry Facilities of Boston College.  All reactions were carried out under a 
nitrogen atmosphere employing oven- and flame dried glassware. All solvents were distilled 
from appropriate drying agents or obtained from passing through activated alumina prior to 
use. 
 
                                                
25 Still, W. C.; Kahn, M.; Mitra, J. J. Org. Chem. 1978, 43, 2923-2925. 
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Allyl glycine methyl ester: 
Allyl glycine (43) (4 g, 34.8 mmol) was stirred in MeOH (100 
mL), HCl was bubbled through the reaction vessel for 2 hours.  The 
reaction vessel was then sealed and allowed to stir overnight at room temperature.  The 
solvent was removed in vacuo and azeotroped with toluene giving a white crystalline solid. 
This solid was carried onto the next step with no further purification. Exact mass calcd. for 
[C12H17NO3SNa]+ requires m/z 278.08 Found 278.02 (ESI+); 1H NMR (D2O, 400 MHz) 5.72-
5.83 (m, 1H), 5.29-5.34 (m, 2H), 4.26 (t, J=8 Hz, 1H), 3.86 (s, 3H), 2.65-2.82 (m, 2H) ppm. 
 
Methyl 2-(4-methylphenylsulfonamido)pent-4-enoate (44): 
Allyl glycine methyl ester HCl was suspended in methylene 
chloride (5.7 mL). To this was added p-toluenesulfonyl chloride (0.362 g, 
1.9 mmol) and triethylamine (0.593 mL, 4.25 mmol).  The reaction was allowed to stir at 
room temperature for 20 hours. The reaction was then washed with water and citric acid (0.5 
M).  Removal of the solvent in vacuo gave a crude brown oil.  This oil was purified via flash 
column chromatography (10%-25% EtOAc/hexanes) giving a clear oil. (0.293 g, 1.0 mmol, 
59% two steps); 1H NMR (CDCl3, 400 MHz) δ 7.72 (d, J=8 Hz, 2H), 7.30 (d, J=12 Hz, 2H), 
5.57-5.68 (m, 1H), 5.10-5.13 (m, 3H), 4.01-4.06 (m, 1H), 3.52 (s, 3H), 2.47 (t, J=6 Hz, 2H), 
2.42 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ 129.8, 128.1, 124.0, 40.7, 34.2, 31.2, 27.7, 
27.3, 26.1, 22.0 ppm. 
  
 
NH2
OMe
O
NHTs
OMe
O
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N-(1-hydroxypent-4-en-2-yl)-4-methylbenzenesulfonamide (45): 
 Lithium aluminum hydride (4 g, 105.5 mmol) was suspended in THF 
(40 mL) and cooled to 0 oC (ice bath).  The N-tosyl allylglycine methyl ester 
44 (5.98 g, 21.1 mmol) was dissolved in THF (30 mL) and added to the solution of lithium 
aluminum hydride (LiAlH4) dropwise via cannula.  The reaction was allowed to warm to room 
temperature upon complete addition of the methyl ester, and stirred at room temperature for 
24 hours.  The reaction was then cooled to 0 oC and quenched with water until bubbling 
ceased.  HCl (15 mL, 3 M) was added and followed by the addition of water causing the 
precipitation of a grey solid.  The solid was then filtered and washed with ethyl acetate.  
Removal of the solvent in vacuo gave an off-white powder. This powder was purified via 
flash column chromatography (20%-50% ethyl acetate/hexanes) giving a white crystalline 
solid (4.65 g, 18.3 mmol, 87% yield); Exact mass calcd for [C12H17NO3SNa]+ requires m/z 
278.08 Found 278.02 (ESI+); 1H NMR (CDCl3, 400 MHz) 7.22 (d, J=12 Hz, 2H), 7.29 (d, 
J=12, 2H), 5.57-5.70 (m, 1H), 5.05-5.15 (m, 3H), 3.92-4.03 (m, 2H), 2.46 (t, J=8 Hz, 2H), 
2.41 (s, 3H), 1.12 (t, J= 8 Hz, 2H) ppm. 
 
2-allyl-1-tosylaziridine (46): 
 To a mixture of amino alcohol 45 (0.148 g, 0.58 mmol) and triphenyl 
phosphine (0.184 g, 0.70 mmol) in THF (1.5 mL) was added diethyl 
azodicarboxylate (DEAD) (0.109 mL, 0.70 mmol).  The mixture was allowed to stir at room 
temperature for 24 hours.  Removal of the solvent in vacuo gave a crude yellow oil.  This oil 
was purified via flash column chromatography (10%-20% ethyl acetate/hexanes).  Fractions 
NTs
OH
NHTs
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containing product were combined and the solvent removed in vacuo to give a yellow oil. 
(0.078g, 0.33 mmol, 57 % yield); Exact mass calcd for [C12H15NO2SNa]+ requires m/z 260.07 
Found 260.07 (ESI+); 1H NMR (CDCl3, 400 MHz) δ 7.82 (d, J=8 Hz, 2H), 7.34 (d, J=12 Hz, 
2H), 5.56-5.66 (m, 1H), 4.97-5.10 (m, 2H), 2.75-2.83 (m, 1H), 2.64 (d, J=8 Hz, 1H), 2.45 (s, 
3H), 2.14-2.30 (m, 2H), 2.10 (d, J=4 Hz, 1H) ppm. 
 
7-methyl oct-6-ene-1-tosylaziridine (8): 
 To a 0 oC stirred solution of aziridine 46 (0.386g, 1.63 mmol) 
in THF (16 mL) was added 9-borabicyclo[3.3.1.]nonane (9-BBN) 
(0.293g, 2.4 mmol)26.  The reaction was allowed to warm to room temperature and stirred for 
3 hours.  DMF was added followed by the dropwise addition of K3PO4 (1.1 mL, 3 M, 
degassed) and the rapid addition of 1-bromo-2-methyl propane (0.184 mL, 1.8 mmol) and 
PdCl2(dppf) (0.065g, 0.08 mmol).  The reaction was stirred at room temperature for 24 hours.  
The THF was removed in vacuo and the DMF was partitioned between diethyl ether and 
NaHCO3 (Sat.).  The aqueous layer was then extracted with ether and the combined organic 
layers were dried over magnesium sulfate.  Removal of the solvent in vacuo gave a crude 
yellow oil.  This oil was purified via flash column chromatography (5%-10% ethyl 
acetate/hexanes). Fractions containing product were combined and the solvent was removed in 
vaccuo giving a yellow oil. (0.097g, 0.33mmol, 20 % yield); TLC Rf .46 (20% 
EtOAc/hexanes); Exact mass calcd for [C16H23NO2SK]+ requires m/z 332.11. Found 333.18 
(ESI+); IR (film, cm-1) 3547, 2924, 2867, 1596, 1451, 1331, 1168, 1092, 928, 815, 721; 1H 
NMR (CDCl3, 400 MHz) δ 7.88 (d, J=12 Hz, 2H), 7.39 (d, J=12 Hz, 2H), 5.04 (t, J=8 Hz, 
                                                
26 Soderquist, J. A.; Negron A. Org. Synth. 1998, 9, 95. 
NTs
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1H), 2.66 (t, J=4 Hz, 1H), 2.55 (d, J=8 Hz, 1H), 2.36 (s, 3H), 1.97 (d, J=4 Hz, 1H), 1.86 (q, 
J=8 Hz, 2H), 1.58 (s, 3H), 1.47 (s, 3H), 1.23 (q, J=8 Hz, 2H) ppm; 13C NMR (CDCl3, 100 
MHz) δ 130.0, 128.0, 124.0, 40.7, 34.2, 31.2, 27.7, 27.3, 26.1, 22.0, 18.1 ppm.  
 
1,1-dimethyl-2-tosyloctahydrocyclopenta[c]pyrrole (9): 
To a 0 oC mixture of aziridine (0.015 g, 0.05 mmol) in methylene 
chloride (0.5 mL) was added BF3•Et2O.  The reaction was allowed to warm to 
room temperature and stirred for 5 hours.  After quenching the reaction with Na2CO3 (sat) the 
product was extracted with methylene chloride.  The combined organic fractions were dried 
over magnesium sulfate and the solvent was removed in vacuo giving a clear oil.  No further 
purification was done: Exact mass calcd for [C16H23NO2SNa]+ requires m/z 316.13 Found 
316.13 (ESI+); 1H NMR (CDCl3, 400 MHz) δ  7.72 (d, J=8 Hz, 2H), 7.27 (d, J=8 Hz, 2H), 
3.64 (t, J=10 Hz, 1H), 3.02 (q, J=4 Hz, 1H), 2.58-2.65 (m, 1H), 2.42 (s, 3H), 2.14 (q, J=8 Hz, 
1H), 1.83-1.91 (m, 2H), 1.68-1.75 (m, 2H), 1.58-1.65 (m, 2H), 1.41 (s, 6H) ppm; 13C NMR 
(CDCl3, 100 MHz) δ 120.5, 127.4, 58.6, 55.2, 39.0, 32.3, 28.7, 28.6, 26.5, 24.7, 21.9 ppm. 
 
NTs
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1H NMR of Allyl glycine methyl ester 
 
1H NMR of Methyl 2-(4-methylphenylsulfonamido)pent-4-enoate (51) 
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1H NMR of N-(1-hydroxypent-4-en-2-yl)-4-methylbenzenesulfonamide (52) 
 
 
1H NMR of 2-allyl-1-tosylaziridine (53) 
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1H NMR of 7-methyl oct-6-ene-1-tosylaziridine (8) 
 
 
 
13C NMR of 7-methyl oct-6-ene-1-tosylaziridine (8) 
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1H NMR of 1,1-dimethyl-2-tosyloctahydrocyclopenta[c]pyrrole (9) 
 
 
13C NMR of 1,1-dimethyl-2-tosyloctahydrocyclopenta[c]pyrrole (9) 
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COSY NMR of 1,1-dimethyl-2-tosyloctahydrocyclopenta[c]pyrrole (9) 
nt=16; ni=512; sfrq=400.022; solvent CDCl3 
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Chapter 2: Kinetic Resolution of 4-hydroxymethyl cyclopent-2-enone 
 
2.1 Kinetic Resolution as a Synthetic Tool 
 There are many benefits associated with kinetic resolutions, including ease of 
purification and the ability to isolate both enantiomers of a compound.  For this reason 
resolutions are a versatile tool in organic synthesis.  Despite the inherent drawback of a 
maximum yield of 50%, on the appropriate system this methodology can provide an excellent 
means for obtaining optically pure substrates. There have been significant efforts in making 
kinetic resolutions applicable for a variety of different reaction types, including reduction, 
oxidation, ring opening, and acylation reactions.27  Complementing the expanding number of 
processes that can be used in performing kinetic resolutions is the effectiveness shown with a 
variety of different catalysts. Organic, organometallic, and enzymatic catalysts have all been 
utilized, with enzymatic methods generally providing the highest levels of selectivity. 28   
The Sharpless asymmetric epoxidation has been used to perform kinetic resolutions on 
various allylic alcohols.  Utilizing a titanium-based catalyst, with tert-butyl hydroperoxide as 
the stoichiometric oxidant, the Sharpless epoxidation allows for access to either enantiomer of 
an allylic alcohol through the use of (+) or (-) tartrate esters as chiral ligands (Scheme 12).29  
                                                
27 (a) Keith, J. M.; Larrow, J. F.; Jacobsen, E. N. Adv. Synth. Catal. 2001, 343, 5-26. (b) 
Nicolaou, K. C.; Vourloumis, D.; Winssinger, N.; Baran, P. S. Angew. Chem. Int. Ed. 2000, 
39, 44-122. 
28 (a) Wong, C.-H. Science 1989 244, 1145-1152. (b) Kazlauskas, R. J.; Weissfloch, A. N. E.; 
Rappaport, A. T.; Cuccia, L. A. J. Org. Chem. 1991, 56, 2656-2665. (c) Kim, M.-J.; Choi, Y. 
K. J. Org. Chem. 1992, 57, 1605-1607. 
29 (a) Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5976-5978. (b) Martin, V. 
S.; Woodard, S. S.; Katsuki, T.; Yamada, Y.; Ikeda, M.; Sharpless, K. B. J. Am. Chem. Soc. 
1981, 103, 6237-6240. (C) Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, 
H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765-5780. 
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This procedure allows for the kinetic resolution of over 170 substrates with high levels of 
selectivity. 
R R1
OH
(+) or (-) tartrate ester
tert-butyl hydroperoxide
Ti(O-i-Pr)4
molecular sieves
R R1
OH
R R1
O
OH
R R1
OH
R R1
O
OH
L-(+)-tartrates
D-(-)-tartrates
Scheme 12: Sharpless asymmetric epoxidation
47
47
47
48
48  
 
2.2 Kinetic Resolutions of Primary Alcohols 
Kinetic resolutions of primary alcohols provide an intriguing challenge in organic 
synthesis.  Compared to secondary alcohols, primary alcohols exhibit higher reactivity 
coupled with a stereocenter further removed, which adds extra challenge to differentiating two 
enantiomers of a substrate.  While progress has been made on the resolution of specific 
substrates, there is still considerable room for improvement.  
The availability of enzymes that have been successfully employed to resolve primary 
alcohols is somewhat low, especially when compared those used to resolve secondary 
alcohols. Intense optimization of conditions through variation of the acylating agent, 
temperature, or the use of additives can be performed to improve the low selectivity observed 
with many lipases used in the kinetic resolution of primary alcohols.30  
                                                
30 (a) Weissfloch, A. N. E.; Kazlauskas, R. J. J. Org. Chem., 1995, 60, 6959-6969. (b) Sakai, 
T.; Kishimoto, T.; Tanaka, Y.; Ema, T.; Utaka, M. Tetrahedron Lett. 1998, 7881-7884. (c) 
Ema, T.; Maeno, S.; Takaya, Y.; Sakai, T.; Utaka, M. J. Org. Chem. 1996, 61, 8610-8616. 
(d) Ke, T.; Wescott, C. R.; Klibanov, A. M. J. Am. Chem. Soc. 1996, 118, 3366-3374. (e) 
Mezzetti, A.; Keith, C.; Kazlauskas, R. J. Tetrahedron: Asymmetry, 2003, 14, 3917-3924. 
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One example of an enzymatic resolution of primary alcohols is demonstrated in the 
work done by T. Miyazawa et al. with Pseudomonas sp. lipase to catalyze the acylation of 2-
aryloxy-1-propanols 49.31  In this study, a number of anhydrides were explored for use as acyl 
donors, with hexanoic anhydride providing optimal selectivity for a variety of substrates 
(Scheme 13).  As is often the case in asymmetric catalysis, lower temperature also contributed 
to the higher selectivity in this reaction.  
O
OH
(RCO)2O
O
OCOR
O
OH
lipase
org. solvent
(S) (R)
Scheme 13: Enzymatic kinetic resolution of 2-aryloxy-1-propanols
R R R
49 -50 -49  
 The effect of temperature on enzymatic resolutions of primary alcohols has also been 
reported by T. Sakai et al. in a study involving the lipase-catalyzed resolution of 5-
(hydroxymethyl)-3-phenyl-2-isoxazoline (51).  This substrate has proven to be an important 
synthetic intermediate in the synthesis of β-hydroxy ketones, γ-amino alcohols, and β-amino 
acids.32  In this work, it was reported that the kinetic resolution of 51 proceeded with poor 
selectivity at room temperature (E=5.9): however, performing the reaction at -60 oC increased 
the selectivity significantly (E=249) (Scheme 14).33 
                                                
31 Miyazawa, T.; Kaito, E.; Yukawa, T.; Murashima, T.; Yamada, T Journal of Molecular 
Catalysis B: Enzymatic  2005, 37, 63-67. 
32 Sakai, T.; Mitsutomi, H.; Korenaga, T.; Ema, T.; Tetrahedron: Asymmetry 2005, 16, 1535-
1539. 
33
! 
E = Krel =
ln[1" c(1+ ee(p))]
ln[1" c(1" ee(P))]
 
Chen, C.-S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J. Am. Chem. Soc. 1982, 104, 7294-7299. 
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Ph
ON
OH
Ph
ON
O
Ph
ON
H
H R
O
OH
lipase PS-C II
organic solvent
OCOR
(R)-a: R=CH3
(R)-b: R=(CH2)2CH3
(R)-c: R=(CH2)2Ph
Scheme 14: Kinetic resolution of 5-(hydroxymethyl)-3-phenyl-2-isoxazoline
-51 52 51
 
Another method that has been utilized to improve the selectivity of a lipase catalyzed 
kinetic resolution is the use of chiral acyl donors.  K. Hirose et al. reported enhanced 
selectivity (E=98) when using chiral acyl donor 54, containing a stereocenter at the β-carbon 
to the carbonyl group, with the lipase SL in diisopropyl ether (Scheme 15).34 
OH
Me
OMe
OMe
OH
Me Me
Scheme 15: Lipase catalyzed resolution of a primary alcohol using a chiral acylating agent
-53
54
5553
O
O
Me
(S,R) 92 % ee
         84 % de
(S,S) 99 % ee
         84 % de
Lipase QL, Hexane
18 % conv.
 
Although enzymes are commonly employed, they do not represent the sole method for 
kinetic resolutions of primary alcohols.  Limited success in performing kinetic resolutions of 
primary alcohols using non-enzymatic methods has also been achieved.  As with secondary 
alcohols, the Sharpless epoxidation provides an excellent method for performing kinetic 
resolutions on primary alcohols.  Hamon and Tuck reported the use of the Sharpless 
                                                
34 Hirose, K.; Naka, H.; Yano, M.; Ohashi, S.; Naemura, K.; Tobe, Y. Tetrahedron: 
Asymmetry 2000, 11, 1199-1210. 
Chapter 2 
 
 
33 
epoxidation in the resolution of primary alcohol 56 in the synthesis of (+)-Grandisol (Scheme 
16).35   
OH OH OH
O
H
OHHO
H
unhindered face leading to 
facile attack of L-(+)-DIPT
hindered face leading to 
slow attack of L-(+)-DIPT
L-(+)-DIPT
Scheme 16: Asymmetric epoxidation in the resolution of a primary allylic alcohol
56 57 56
 
 
2.3 Desymmetrization of Glycerol Derivatives 
Glycerol provides an interesting and useful substrate for the study and application of 
kinetic resolutions on primary alcohols.  Glycerol is a triol that provides the backbone for 
many biological compounds such the phosphatidylinositol phosphate family of natural 
products.36  
Examples for the preparation of optically active glycerol derivatives include recent 
work that has focused on kinetic resolutions involving both enzymatic and non-enzymatic 
catalysts.  Recently, a method involving the use of small proline-based catalyst 59 was 
reported in the resolution of a protected glycerol derivative 58.  With this technique it was 
possible to achieve 97 % ee at 60 % conversion giving a 29 % yield of the desired enantiomer  
(Scheme 17).37 
                                                
35 Hamon, D. P. G.; Tuck, K. L. J. Org. Chem. 2000, 65, 7839-7846. 
36 (a) Martin, T. F. J. Annu. Rev. Cell Developmental Biol. 1998, 14, 231-264. (b) Czech, M. 
P. Cell 2000, 100, 603-606. 
37 Terakado, D.; Koutaka, H.; Oriyama, T. Tetrahedron: Asymmetry 2005, 16, 1157-1165. 
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Me
Bn
i-Pr2NEt (0.5 eq.)/ MS 4 A
CH2Cl2 / -78 
oC / 3 h
OCOAr
O
O
R
R
OH
O
O
R
R
62% yield
48% ee
29% yield
97% ee
Ar=4-MeC6H4
Scheme 17: Kinetic resolution of glycerol with proline based catalyst
58
59
60 58
 
 Similar to kinetic resolutions of other primary alcohols, lipases have shown promise 
in the desymmetrization of glycerol derivatives.  In particular, the use of porcine pancreatic 
lipase (PPL) was shown to give selectivity (96 % ee with 63 % yield) in the desymmetrization 
of glycerol 61 (Scheme 18).38 
OH
OBz
OAc
OBzPPL, vinyl acetate
THF, hexane
63% yield
96% ee
Scheme 18: Enzymatic desymmetrization of glycerol
61 62
HO HO
 
As an ongoing investigation of peptides as acyl transfer catalysts, the Miller lab has 
focused efforts on developing a catalyst for the desymmetrization of glycerol derivatives.39  A 
solution to this challenge was the use of pentameric peptides containing the catalytic π-
methyl-histidine residue.40  Control of the peptides’ secondary structures was achieved by 
                                                
38 Bodai, V.; Novak, L.; Poppe, L. Synlett 1999, 6, 759-761. 
39 The advantage of desymmetrization over kinetic resolutions is a theoretical 100% 
conversion with a >98 %ee leading to a more efficient process. 
40 (a) Miller, S. J.; Copeland, G. T.; Papaioannou, N.; Horstmann, T. E.; Ruel, E. M. J. Am. 
Chem. Soc. 1998, 120, 1629-1630. (b) Jarvo, E. R.; Copeland, G. T.; Papaioannou, N.; 
Bonitatebus, P. J. Jr.; Miller, S. J. Am. Chem. Soc. 1999, 121, 11638-11643. 
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using D-proline at the i+1 position, presumably forcing a β-hairpin in the peptide backbone 
(Figure 2).41 
Figure 2: Pentameric peptides containing a !-turn
N
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MeO
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As expected, bridging from the kinetic resolution of secondary alcohols to primary 
alcohols required the optimization of reaction conditions, with temperature being a prevalent 
factor in controlling selectivity.  Compared with secondary alcohols, where excellent 
selectivity was observed at room temperature, optimal conditions for glycerol involved 
lowering the temperature to -50 oC. 42  Further optimization of reaction conditions indicated 
that addition of extra acetic anhydride led to higher optical purity.  Presumably this boost in 
enantiomeric purity results from a secondary kinetic resolution occurring under these reaction 
conditions (Scheme 19).43 
                                                
41 Blank, J. T.; Guerin, D. J. Miller, S. J. Org. Lett. 2000, 2, 1247-1249. 
42 Lewis, C. A.; Sculimbrene, B. R.; Xu, Y.; Miller S. J. Org. Lett. 2005, 7, 3021-3023. 
43 Schreiber, S. L.; Schreiber T. S.: Smith, D. B. J. Am. Chem. Soc. 1987, 109, 1525-1529. 
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Scheme 19: Desymmetrization of  glycerol
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2.4 Use of 4-Hydroxymethyl Cyclopent-2-enone (76) 
In an effort to further expand the utility of peptides as asymmetric catalysts the kinetic 
resolution of 4-hydroxymethyl cyclopent-2-enone (76) was investigated.  This work was 
initiated through collaboration with the Gleason group from McGill University.  
4-Hydroxymethyl cyclopent-2-enone (76) provides a synthetically useful intermediate that 
challenges the limitations of kinetic resolutions.  
The Gleason group has discovered that 5-substitued cyclopentadienes 67 undergo 1,5-
hydride-shifts at low temperature (-20 oC).  By hydroxylating 5-substituted cyclopentadienes 
67 at the 2-position the compound gains thermal stability (Scheme 20A).  The Gleason group 
has shown that these compounds can undergo a variety of cycloaddition reactions.  Utilizing 
this chemistry, efforts in that group are currently focused on the total synthesis of Palau’amine 
(71) and the core of the CP class of natural products, CP 225,917 (74) (Scheme 20).44 
                                                
44 Unpublished results from the Gleason group 
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Scheme 20: Use of 4-hydroxymethyl-cyclopent-2-enone by the Gleason group
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Along with providing a key intermediate for the synthesis of palau’amine and the CP 
class of natural products, 4-hydroxymethyl cyclopent-2-enone (76) provides a synthetic 
intermediate for other natural products as well.  In particular, this intermediate was utilized in 
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the synthesis of aristeromycin (77)45 and carbocyclic dideoxyhydronucleosides 75,46 along 
with the prostaglandin precursor 15-F2C-IsoP (79) (Scheme 21).47  
N
HO
N
N
NH
OH
OH
HO
carbocyclic coformycin (75)
N
NN
N
H2N
OH
OH
HO
(-)-aristeromycin (77)
HO
O
O
OH
O
O
HO
HO
C5H11
HO
(CH2)3COOH
15-F2c-IsoP (79)
Scheme 21: Use of 4-hydroxymethylcyclopent-2-enone (76) in organic synthesis
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76 78  
 
2.5 Preparation of 2-Hydroxymethyl Cyclopent-2-enone (76) 
Previously reported methods for the synthesis of 2-hydroxymethyl cyclopent-2-enone 
(76) involve multiple steps with a low overall yield.  Also problematic for these methods is the 
necessity to separate diastereomers to achieve optically active material.  These problems make 
these methods unsuitable for large-scale production.48  Cortez et al. reported one of the most 
                                                
45Yokato, Y.; Cortez, G. S.; Romo, D. Tetrahedron 2002, 58, 7075-7080.   
46Saville-Stones, E. A.; Turner, R. M.; Lindell, S. D.; Jennings, N. S.; Head, J. C.; Carver, D. 
S. Tetrahedron 1994, 50, 6695-6704.  
47Zanoni, G.; Re, S.; Meriggi, A.; Castronovo, F.; Vidar, G. Tetrahedron: Asymmetry 2001, 
12, 1785-1792. 
48 Yokato, Y.; Cortez, G. S.; Romo, D. Tetrahedron 2002, 58, 7075-7080.  
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efficient syntheses of this alcohol, involving a nucleophilic catalyzed aldol lactonization 
(NCAL) (Scheme 22).49  
O
O
CHO
CO2H
NCAL
O
O
O
O
1.) BH3 DMS
2.) 1N HCl/THF
HO
O
Scheme 22: Aldol lactonization
80 81 76  
In overcoming this problem, the Gleason group has developed a four step synthetic 
method for the preparation of racemic 2-hydroxymethyl cyclopent-2-enone (76).50  The first 
step to this synthesis is a Prins reaction, in which cyclopentadiene is treated with 
paraformaldehyde, p-toluenesulfonic acid and formaldehyde.  Unfortunately, this reaction 
results in a mixture of four distinct products, complicating the purification and making the 
protection of the alcohol necessary for isolation of the desired product.  Further oxidation of 
the allylic alcohol selectively, using Bobbitt’s reagent, gives the desired product (Scheme 23). 
(H2CO)3
p-TsOH
HCOH
O
TBSO
HO
OH
HO
OH
OH
OH OH OH
HO
OH
HO
OH
1. Bobbitt's reagent, CH2Cl2
2. TBSCl, imidazole, CH2Cl2
Scheme 23: Gleason group synthesis of 4-hydroxymethyl-cyclopent-2-enone (76)
76
 
                                                
49 (a) Cortez, G. S.; Tennyson, R. L.; Romo, D. J. Am. Chem. Soc. 2001, 123, 7945-7946. (b) 
Yokota, Y.; Cortez, G. S.; Romo, D. Tetrahedron 2002, 58, 7075-7080. 
50 unpublished results from Gleason group 
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Despite the ability of 2-hydroxymethyl cyclopent-2-enone (76) to be synthesized on 
large scale there are limitations associated with the procedure developed by Gleason.  The 
formation of multiple products and the lack of an enantioselective process hinder the 
effectiveness of this procedure in preparing intermediates in the synthesis of optically active 
natural products.  To strengthen this methodology, the possibility of utilizing a peptide to 
perform a kinetic resolution of the product was investigated.  Additionally, it was envisaged 
that this peptide or an alternative peptide might be able to perform a resolution of the different 
regioisomers produced in the Prins reaction.  By utilizing a kinetic resolution in this 
procedure, isolation of both enantiomers of 2-hydroxymethyl cyclopent-2-enone (76) is 
possible. 
 
2.6 Results and Discussion 
Successful application of pentameric peptides in the desymmetrization of glycerol 
prompted the use of these catalysts for the initial investigation into the kinetic resolution of 2-
hydroxymethyl cyclopent-2-enone (76).  As in the glycerol project, attention was focused on 
β-turn peptides containing D-proline at the i+1 position, with π-methylhistidine used as the 
catalytic moiety.  The initial screen revealed interesting results, with one peptide (Table 2, 
entry 1) showing moderate selectivity (krel=1.2).  For the initial screen the reaction was run at 
-30 oC with one equivalent of Hünig’s base and 5 mol % peptide in chloroform (Scheme 
24).51,52 
                                                
51 In the initial screen ee was determined by Chiral HPLC and conversion by 1H NMR 
52 Initial Screen preformed with help from Chad Lewis 
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O
OH
O
OH
O
OAc
5 mol % peptide
Ac2O, Hunigs base
CHCl3, -30
oC
N
N
Me
NHBoc
O
N
N
H
O
HN
O
O NH
R'
OMe
O
R''
i
i+1
i+2
i+3
i+4
R
Scheme 24: Kinetic resolution of 4-hydroxymethyl cyclopent-2-enone (76)
-76 -76 82
 
entry Peptide ee(Prod)**conv.*
i+1 i+2 i+3 i+4
1
2
3
4
5
6
7
8
PMH D-Pro
PMH
PMH
PMH
PMH
PMH
PMH
PMH
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
Abu
Chg
Dbg
D-HPhe
Ile
Leu
Asp(Obut)
Phe D-Phe
D-Phe
D-Phe
D-Phe
D-Phe
D-Phe
D-Phe
Phe
Phe
Phe
Phe
Phe
D-Phe
9
10
11
12 PMH D-Pro Asn(Trt) Phe D-Phe
His(Bzl)
HPhe
63% -13%
80% -8%
78% -11%
78% -13%
79% -19%
70% -3%
80% 10%
73% -11%
80% -13%
86% -13%
Phe
Phe
Phe D-PheD-ProPMH
13
14
PMH D-Pro
PMH
PMH
D-Pro
D-Pro
PMH D-Pro
Phg Phe D-Phe
Sp6 Phe D-Phe
Sp8 Phe D-Phe
D-Val Phe D-Phe
82% -10%
63% -8%
72% -10%
63% 6%
* Conversion determined by NMR
** ee Determined by Chiral HPLC
Table 2: Initial screen of 4-hydroxymethyl cyclopent-2-enone
 
Further reaction optimization demonstrated that lower temperatures contribute 
significantly to the selectivity observed.  By lowering the reaction temperature to -50 oC, 
reactivity was conserved while the selectivity increased from a krel=1.3 to a krel=3.5 for the 
lead peptide (Table 2, entry 2).  From this preliminary optimization two lead peptides (Table 
2, entries 1 and 2) provided moderate selectivity (krel’s=3.7 and 3.5 respectively). These 
peptides were the basis on which further catalyst optimization was built. 
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entry Peptide ee(Prod)**conv.*
i+1 i+2 i+3 i+4
1
2
3
4
5
6
7
8
PMH D-Pro
PMH
PMH
PMH
PMH
PMH
PMH
PMH
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
D-Pro
Abu
Chg
Dbg
D-HPhe
Ile
Leu
D-Trp(Boc)
Phe D-Phe
D-Phe
D-Phe
D-Phe
D-Phe
D-Phe
D-PheTyr(Bn)
Aib
Phe
Phe
Phe
Phe
Phe
D-Phe
42%
51%
44%
49%
56%
52%
43%
50%
-17%
-23%
-34%
17%
-20%
-23%
-9%
43%
* Conversion determined by NMR
** ee Determined by Chiral HPLC
D-Asp(Ot-Bu)
Table 3: Temperature effects on the kinetic resolution of 4-hydroxymethyl cycloopent-2-enone
ee(Prod)**conv.*
-30 oC -50 oC
-- --
79% -19%
78% -13%
86% -13%
80% -13%
63% -13%
80% 10%
-- --
 
Upon further examination of these two catalysts (table 2, entries 1 and 2) the 
difference in selectivity observed of interest due to the similarities in structure of both 
peptides (Figure 3).  Entry 1 has a Boc protected D-tryptophan [D-trp(Boc)] at the i+3 
position and entry 2 contains an L-phenylalanine (Phe) at that same position.  Both peptides 
contain a geminally substituted aliphatic amino acid at i+2 and D-phenylalanine at the 
terminal i+4 position.  Of particular interest in this data is that while the same antipode of π-
methylhistidine is used in all these peptides, selectivity of the two lead catalysts is for 
different enantiomers of the substrate. 
N
N
Me
NHBoc
O
N
N
H
O
HN
O
O NH
OMe
O
N
N
Me
NHBoc
O
N
N
H
O
HN
O
O NH
OMe
O
NBoc
n-Bun-Bu Me Me
44 % conv.*
(-) 34 %ee**
krel=2.6
50 % conv.*
(+) 43 %ee**
krel=3.7
Figure 3: Lead catalyst after preliminary screen
 
The analytical technique utilized for determination of enantioselectivity and 
conversion also required optimization.  Initial analysis for the peptide screens were 
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preformed utilizing chiral HPLC for selectivity, and 1H NMR for conversion.  This method 
required a 60 min HPLC method and provided no separation for the starting material: only 
for the acylated product.  Because of the volatility associated with both the product and 
starting material it was decided to utilize chiral GC for the determination of both conversion 
and selectivity.  This method allowed for the separation of both product and starting material 
enantiomers in less time, making a higher throughput screening technique practical. 
A number of peptide libraries were prepared and studied in an effort to establish 
further understanding of this system.  Using a systematic approach for catalyst optimization, 
each position of the peptides was altered individually while conserving the rest of the 
catalyst. Various amino acids were used to investigate effects of stereochemistry, size and 
electronics at individual locations within the peptide (Table 4).53 
AibPMH D-Pro
PMH D-Pro
PMH D-Pro
Aib
D-Cha Gly
D-1-Nal Gly
Aib D-Lys(Boc) Gly
1
2
3
55% -49% 57% 3.9 6.9
40% -24% 53% 2.7 4.5
36% -22% 51% 2.8 4.0
entry Peptide ee(Prod)*conv.* krel(prod)**ee(SM)* krel(SM)**
i+1 i+2 i+3 i+4
PMH
PMH
PMH
D-Pro
D-Pro
D-Pro
Aib
Aib
Aib
D-Trp(Boc)
D-Trp(Boc)
D-Trp(Boc)
Gly
Ala
Trp(Boc)
72% 43% 4.6
59% 47% 5.3
56% 46% 4.8
4
5
6 -66% 5.0
-52% 3.5
-44% 3.1
7 PMH D-Pro D-Val D-Trp(Boc) Gly 30% -20% 57% 3.3 4.8
* Conversion ane ee's determined by Chiral GC
** krel's calculated according to the method of Kagan: 
    (Kagan, H. B.; Fiaud, J. C. Top. Stereochem. 1998, 18, 249-330)
Table 4: Top catalyst for the kinetic resolution of 4-hydroxy cyclopent-2-enone
 
The peptides giving the highest selectivity exhibit some common structural features.  
Of particular notice is the importance of stereochemistry at the i+3 position.  Both D- and 
L- amino acids were incorporated at this position with a noticeable enhancement in 
selectivity observed with D-amino acids.  Apart from the stereochemistry at the i+3 
                                                
53 For a complete list of peptides screened see the appendix, Page 48 
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position, the choice of amino acid side chain also plays an important role.  Of all the amino 
acids screened at this position, the highest selectivity was seen with D-cyclohexylalanine 
(D-Cha), (1-naphthyl)-D-alanine (D-1-Nal) and D-tryptophan [D-trp(Boc)].   
To further understand the selectivity of this system, a model was constructed in an 
effort to predict the binding between the substrate and catalyst (Figure 4). Assuming the β-
turn confirmation of the peptide remains in place during this reaction, the selectivity 
observed can be traced to the substrate orientation.  Further hypothesizing that the substrate 
catalyst binding is a result of a hydrogen bond between the amide of the i+2 amino acid and 
the enone of the substrate, there are four possible ways in which the substrate can align itself 
with the peptide (Figure 4 A-D). 
Drawing on the fact that the R enantiomer is being acylated at a higher rate than the 
S enantiomer, the binding of the substrate with the catalyst is further reduced to two 
possibilities (Figure 4, A and D).  From preliminary data, both of these possibilities can be 
used to justify the outcome observed for the top peptides.  Selectivity in this system would 
result from either a positive electronic interaction with the enone and a π-system at the i+3 
position, (1-naphthyl)-D-alanine (D-1-Nal) and D-tryptophan [D-trp(Boc)].  Alternatively, a 
negative steric interaction between the sp3 carbon of cyclopentane and the amino acid at the 
i+3 position causes this orientation to be disfavored, D-cyclohexylalanine (D-Cha).   
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R''
N N
O
H
O
HO
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NH
O
MeO
O
R''NH
Boc
N
N
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N N
O
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NO H
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O
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O
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N
N
Me
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O
Plane of peptide 
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PMH R''
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O
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Figure 4: Potential binding of substrate to peptide
Leads to R enantiomer 
being acylated
Leads to S enantiomer 
being acylated
R R
R' R'
HO
R''H
O
R''
H
O
OHOH
Leads to S enantiomer 
being acylated
Leads to R enantiomer 
being acylated
PMHPMH
A B
C D
 
 
2.7 Conclusion 
Future experiments would help to demonstrate the accuracy of this model. Initial 
experiments that could be performed would be to insert a stronger hydrogen bond donating 
amino acid residue in the i+2 position, leading to stronger binding of the catalyst with the 
substrate.  Along these same lines, it would be interesting to replace the amide bond believed 
to be involved in binding with an alkene isostere to observe the selectivity when that 
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hydrogen bond donor is removed.  Another interesting experiment to perform would be a 
truncation of the peptide to explore the selectivity seen when different residues are removed. 
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2.8 Experimental 
General procedure for the kinetic resolution of 4-hydroxymethylcyclopent-2-enone (76) 
 The alcohol was dissolved in CHCl3 and cooled to -50 oC.  To this solution 
was added Et3N and the catalyst (50 µM in CH2Cl2).  The reaction was stirred at       
-50 oC for 20 min at which time the acetic anhydride was added.  The reaction stirred 
at -50 oC for 12 hours and was quenched with MeOH.  Purification of the individual 
reactions was done by running the crude material through a short plug of silica gel eluting 
with Et2O.  Removal of the solvent in vacuo gave a clear oil.  Analysis of this reaction via 
chiral gas chromatography: Chiral BDM column, 30 meters, 0.25 mm diameter, flow rate at 
150 oC, 15 min. retention times product 8.841 min (R) enantiomer 9.246 min (S) enantiomer 
Starting material 11.725 min (S) enantiomer 12.597 min (R) enantiomer. 
 
Absolute stereochemistry was determined by the optical rotation of the isolated starting 
material from the kinetic resolution, purified by flash column chromatograph and eluting 
with 100 % ether. 
 
! 
["]
D
25
=-27. (c= 1, CH2Cl2) for -66% ee: Giving the (S) enantiomer. 
Literature value (R) enantiomer: 
! 
["]
D
25
=+159 (c 0.5, CH2Cl2)54 
 
General Procedure for Preparation of Peptide Using Solid Phase Synthesis 
 Peptides were synthesized on solid support using commercially available Wang 
polystyrene resin preloaded with the desired FMOC protected termial amino acid.  Couplings 
were performed using 5 equiv amino acid derivative, 5 equiv HBTU, and 10 equiv Hunig’s 
                                                
54 (a) Cortez, G. S.; Tennyson, R. L.; Romo, D. J. Am. Chem. Soc. 2001, 123, 7945-7946. (b) 
Yokota, Y.; Cortez, G. S.; Romo, D. Tetrahedron 2002, 58, 7075-7080. 
O
AcO
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base in DMF, for 3 h.  Deprotections were performed using 20% piperdine in DMF for 20 
min (to minimize diketopiperazine formation; dipeptides were deprotected using 50% 
piperdine in DMF for 5 min).  Peptides were cleaved from solid support using a mixture of 
MeOH:DMF:NEt3 (9:1:1) for 5 d.  The peptides were used in parallel reaction screens 
without further purification. 
 
Amino acid abbreviations 
Aib: Aminoisobutyric Acid 1-Nal: 1-Napthylalanine 
Ala: Alanine Phe: Phenylalanine 
Arg: Arginine Phg: Phenylglycine 
Cha: Cyclohexylalanine Pip: Pipecolic acid 
Chg: Cyclohexylglycine Pro: Proline 
Deg: Diethylglycine PMH: π-methyl Histidine 
Gly: Glycine Ser: Serine 
His: Histidine Thr: Threonine 
Ile: Isoleucine Trp: Tryptophan 
Leu: Leucine Tyr: Tyrosine 
Lys: Lysine Val: Valine 
Met: Methionine  
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Peptides Screened in the Kinetic Resolution of 4-Hydroxymethyl cyclopent-2-enone (76) 
Entry Peptide ee sm ee prod Conv. 
1 PMH-ProD-ValD-TrpD(Boc)-Leu -24.7 56.7 46 
2 PMH-ProD-ValD-TrpD(Boc)-Gly -19.9 58.1 30 
3 PMH-ProD-Aib-1-NalD-Gly -23.8 52.7 40 
4 PMH-ProD-LysD(Boc)-TrpD(Boc)-Gly -14.4 56.6 21 
5 PMH-ProD-ArgD(Mtr)-TrpD(Boc)-Gly -17.1 51.1 33 
6 PMH-ProD-ChgD-TrpD(Boc)-Gly -14.8 54.0 24 
7 PMH-ProD-ChaD-TrpD(Boc)-Gly -10.5 49.8 15 
8 PMH-ProD-Cha-TrpD(Boc)-Gly -5.7 31.6 18 
9 PMH-ProD-Val-TrpD(Boc)-PheD 1.8 -1.5 57 
10 PMH-ProD-ValD-TrpD(Boc)-PheD -43 32 60 
11 PMH-ProD-Chg-TrpD(Boc)-PheD 3.2 -4.7 66 
12 PMH-ProD-Leu-TrpD(Boc)-PheD -11 18 35 
13 PMH-ProD-Phe-TrpD(Boc)-PheD -6.8 11 39 
14 PMH-ProD-Ser(Bn)-TrpD(Boc)-PheD <5 <5 39 
15 PMH-ProD-Lys(Boc)-TrpD(Boc)-PheD -6.4 9.8 37 
16 PMH-ProD-Ile-TrpD(Boc)-PheD <5 <5 47 
17 PMH-ProD-Met-TrpD(Boc)-PheD -8.3 13 38 
18 PMH-ProD-ProD-TrpD(Boc)-PheD <5 <5 44 
19 PMH-ProD-PheD-TrpD(Boc)-PheD <5 <5 38 
20 PMH-ProD-His(Trt)-TrpD(Boc)-PheD <5 <5 40 
21 PMH-ProD-Trp(Boc)-TrpD(Boc)-PheD -9.7 15 41 
22 PMH-ProD-Phg-TrpD(Boc)-PheD -9.9 9.5 44 
23 PMH-ProD-Deg-TrpD(Boc)-PheD -23 25 51 
24 PMH-ProD-Phe-Phe-PheD -21 10 38 
25 PMH-ProD-Deg-Phe-PheD 9.1 -12.4 49 
26 PMH-ProD-His(Trt)-PheD 5.6 -5.7 61 
27 PMH-ProD-Trp(Boc)-Phe-PheD 9.6 -15 43 
28 PMH-ProD-Deg-Phe-Val -5 <5 46 
29 PMH-ProD-Deg-Phe-Ala <5 -6 41 
30 PMH-ProD-Deg-Phe-Trp(Boc) <5 <5 41 
31 PMH-ProD-Deg-Phe-Gly <5 <5 54 
32 PMH-ProD-Aib-Ala-PheD -3.7 5.3 47 
33 PMH-ProD-Aib-AlaD-PheD -31.7 31.8 51 
34 PMH-ProD-Aib-Gly-PheD -9.9 9.8 53 
35 PMH-ProD-Aib-Thr(Bn)-PheD -9.8 11.2 50 
36 PMH-ProD-Aib-Thr(tBu)-PheD -14.1 13.8 50 
37 PMH-ProD-Aib-Tyr(tBu)-PheD 6.5 -6.4 52 
38 PMH-ProD-Aib-Arg(Pbf)-PheD 5.7 -7.4 59 
39 PMH-ProD-Aib-TrpD(Boc)-Val -25 32 44 
40 PMH-ProD-Aib-TrpD(Boc)-Ala -52 47 59 
41 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc) -44 46 56 
42 PMH-ProD-Aib-TrpD(Boc)-Gly -66 43 72 
43 PMH-ProD-Aib-TrpD(Boc)-Phe-PheD -58 30 68 
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Entry Peptide ee sm ee prod Conv. 
44 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-PheD -33 18 63 
45 PMH-ProD-Aib-Phe-Phe-PheD <5 -19 74 
46 PMH-ProD-Aib-Phe-Trp(Boc)-PheD <5 <5 65 
47 PMH-ProD-Aib-Aib-Trp(Boc)-PheD -12 12 49 
48 PMH-ProD-Aib-TrpD(Boc)-Leu-PheD -38 34 46 
49 PMH-ProD-Chg-Phe-Aib-PheD <5 -17 25 
50 PMH-ProD-Chg-TrpD(Boc)-Gly-PheD <5 <5 19 
51 PMH-ProD-Aib-TrpD(Boc)-Gly-Ala -13.5 39.8 28 
52 PMH-ProD-Aib-TrpD(Boc)-Gly-Ala -14.4 46.0 23 
53 PMH-ProD-Aib-TrpD(Boc)-Gly-AlaD -10.5 42.6 21 
54 PMH-ProD-Aib-TrpD(Boc)-Gly-Bala -16.5 39.1 36 
55 PMH-ProD-Aib-TrpD(Boc)-Gly-Gly -27.4 50.1 38 
56 PMH-ProD-Aib-TrpD(Boc)-Gly-Val -6.6 41.8 12 
57 PMH-ProD-Aib-TrpD(Boc)-Gly-Trp(Boc) -13.4 53.8 19 
58 PMH-ProD-Aib-TrpD(Boc)-Gly-Aib -2.5 36.7 11 
59 PMH-ProD-Aib-TrpD(Boc)-Ala-PheD -17.6 39.0 40 
60 PMH-ProD-Aib-TrpD(Boc)-Ala-Ala -17.7 38.0 31 
61 PMH-ProD-Aib-TrpD(Boc)-Ala-AlaD -8.9 32.0 25 
62 PMH-ProD-Aib-TrpD(Boc)-Ala-Bala -15.8 31.2 40 
63 PMH-ProD-Aib-TrpD(Boc)-Ala-Gly -21.1 31.0 49 
64 PMH-ProD-Aib-TrpD(Boc)-Ala-Val -5.8 20.3 16 
65 PMH-ProD-Aib-TrpD(Boc)-Ala-Trp(Boc) -15.3 34.0 29 
66 PMH-ProD-Aib-TrpD(Boc)-Ala-Aib 0.0 15.5 1 
67 PMH-ProD-Aib-TrpD(Boc)-AlaD-PheD -19.4 38.5 34 
68 PMH-ProD-Aib-TrpD(Boc)-AlaD-Ala -10.5 34.9 23 
69 PMH-ProD-Aib-TrpD(Boc)-AlaD-AlaD -17.3 25.2 41 
70 PMH-ProD-Aib-TrpD(Boc)-AlaD-B-ala -20.8 41.0 34 
71 PMH-ProD-Aib-TrpD(Boc)-AlaD-Gly -18.1 46.8 28 
72 PMH-ProD-Aib-TrpD(Boc)-AlaD-Val -6.5 28.5 15 
73 PMH-ProD-Aib-TrpD(Boc)-AlaD-Trp(Boc) -11.4 37.4 23 
74 PMH-ProD-Aib-TrpD(Boc)-AlaD-Aib -1.0 13.4 13 
75 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-PheD -34.1 45.4 47 
76 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Ala -20.5 51.1 33 
77 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-AlaD -17.9 49.3 30 
78 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Bala -29.1 45.2 42 
79 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Gly -40.6 48.5 53 
80 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Val -4.7 27.2 11 
81 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Trp(Boc) -0.5 0.3 11 
82 PMH-ProD-Aib-TrpD(Boc)-TrpD(Boc)-Aib -2.8 11.8 24 
83 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-PheD -28.0 27.2 57 
84 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Ala -31.9 41.1 46 
85 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-AlaD -16.6 27.8 35 
86 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Bala -9.3 22.1 29 
87 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Gly -27.4 27.8 54 
88 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Val -3.3 14.7 16 
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Entry Peptide ee sm ee prod Conv. 
89 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Trp(Boc) -12.4 26.4 34 
90 PMH-ProD-Aib-TrpD(Boc)-Trp(Boc)-Aib -1.3 18.1 0 
 
 
  
Gas Chromatography Calibration for 4-Hydroxymethyl cyclopent-2-enone (76) 
Standard solutions of 4-hydroxymethyl cyclopent-2-enone 82 and the OAc product 
were prepared (0.017 M in ethyl ether).  These solutions were then combined in known 
amounts and run with the GC conditions previously reported.  Data for this calibration is 
recorded in the table below. 
 
 
Entry Volume OH 
(uL) 
Volume OAc 
(uL) 
Total volume 
(uL) 
Area OH Area OAc 
1 300 0 300 524 0 
2 270 30 300 475 53 
3 240 60 300 411 135 
4 210 90 300 345 210 
5 180 120 300 295 268 
6 150 150 300 241 352 
7 120 180 300 194 401 
8 90 210 300 128 446 
9 60 240 300 76 536 
10 30 270 300 54 615 
11 0 300 300 0 717 
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Chapter 3: Kinetic Resolution of Aliphatic Alcohols 
 
3.1 Hydrogen Bonding in Peptide Catalysts 
 Central to the selectivity of peptide catalysts developed by the Miller group is the idea 
of positive non-covalent interactions between the substrate and catalyst. Presumably the most 
prevalent interaction exploited is a hydrogen bond between the amide of the peptide 
backbone (acting as a hydrogen bond donor) and a hydrogen bond acceptor of the substrate.  
In demonstrating the importance of this hydrogen bond interaction, studies were preformed 
incorporating alkene isosteres in place of the amide bonds of certain peptides. The initial 
hypothesis revolved around a key interaction between the acetamide of the substrate and the 
amide bond of the amino acid located at the apex of the β-turn (Scheme 25).55 
                                                
55 Miller, S. J. Acc. Chem. Res. 2004, 37, 601-610. 
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HO NHAc
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Scheme 25: Kinetic resolution of secondary alcohols
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Results from these studies have demonstrated that this interaction is pivotal in 
providing selectivity for smaller pentameric peptides; however, that same interaction is not as 
crucial in the longer octameric peptides.  Based on this data, the ability of peptides to interact 
and differentiate between two enantiomers of an aliphatic substrate (lacking a hydrogen bond 
donor or acceptor) is brought to light.  Performing kinetic resolutions on aliphatic secondary 
alcohols presents a system allowing for this type of study.  Along with providing interesting 
substrates to study, a reliable method for the preparation of optically active aliphatic 
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substrates, which are synthetically relevant intermediates in the synthesis of natural products, 
would be a significant contribution to synthetic methodology. 
 
3.2 Aliphatic Systems in Nature 
 The ability of enzymes to selectively bind with small molecules is important for many 
successful biological processes.  While enzymes utilize myriad tools for this process, one of 
the more prevalent of these is the hydrophobic effect.  This interaction is not only thought to 
play an important role in protein folding but also in substrate recognition. The important role 
that hydrophobic interactions play may be a reason for the abundance of natural products 
containing hydrophobic, unfunctionalized, side chains.  The ability to synthesize these 
natural products, along with analogs, would aid in furthering our understanding of biological 
processes and provide potentially new and powerful therapeutic agents. 
One class of enzymes that bind to aliphatic substrates are aminopeptidases.  These 
enzymes are responsible for the hydrolysis of amino acids from the N-terminis of peptides, 
and are important for cellular functioning.  There are two classes of aminopetidases: those 
that hydrolyze specific amino acids, and those responsible for hydrolyzing hydrophobic 
residues.  Inhibition of amino acid specific methionyl aminopeptidases (MetAP) has been 
shown to be an effective method of suppressing blood vessel formation and provides 
potential anticancer activity.56  Inhibition of aminopeptidases from the hydrophobic 
hydrolase class could also be effective in preventing the formation of vasculature in tumor 
cells, along with inhibiting the growth and proliferation of cancer cells.  Ustynyuk et al. have 
                                                
56 Liu, S.; Widom, J.; Kemp, C. W.; Crews, C. M.; Clardy, J. Science 1998, 282, 1324-1327. 
Chapter 3 
 
 
55 
shown that certain aliphatic alcohols are effective at inhibiting this type of aminopeptidase 
through competitive binding in the hydrophobic pocket.57 
Apart from being potential anticancer agents, aliphatic sidechains are commonly 
found in natural products.  Recently isolated natural products are the Caminoside family 85 
and Awajanomycin (86) (Figure 5).  Caminoside A (85A), isolated from the sponge Caminus 
sphaeroconia, was shown to act as an antimicrobial agent through inhibition of the bacterial 
type III secretory system.58 Awajanomycin was isolated from the marine-derived fungus 
Acremonium sp. AWA16-1, and has shown cytotoxic activity against A549 cells  (human 
lung adenocarcinoma).59  
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Figure 5: Caminoside Natural products
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 Another important class of natural products containing aliphatic side chains are 
glycolipids.  These molecules consist of aliphatic alcohols bound to sugars and are prevalent 
                                                
57 Ustynyuk, L.; Bennett, B.; Edwards, T.; Holz, R. C.; Biochemistry 1999, 30, 11433-11439. 
58 Linington, R. G.; Robertson, M.; Gauthier, A.; Finlay, B. B.; Soest, R. v.; Anderson, R. J. 
Org. Lett. 2002, 4, 4089-4092. 
59 Jang, J.-H.; Kanoh, K.; Adachi, K.; Shizuri, Y. J. Nat. Prod. 2006, 69, 1358-1360. 
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in cell membranes of a significant number of organisms.  The immunosuppressive activity of 
glycolipids isolated from Plakortis simplex, known as glycolipids simplexides, has sparked 
interest in their study.60  Recently Costantino et al. isolated and identified clathrosides A-C 
(87) and isoclathrosides A-C (88), which represent a unique family of glycolipids (Figure 
6).61 
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Figure 6: Recently isolated glycolipids
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3.3 Production of Enantiomerically Pure Aliphatic Substrates 
While aliphatic sidechains are prevalent in several natural products, the ability to 
prepare them in optically pure form provides a significant challenge in organic chemistry.  
The lack of methodology for the preparation of optically active aliphatic chains is due in part 
                                                
60 Costantino, V.; Fattorusso, E.; Mangoni, A.; M. Di Rosa, M.; Ianaro, A. Bioorg. Med. 
Chem Lett. 1999, 9, 271-276. 
61 Costantino, V.; Fattorusso, E.; Imperatore, C.; Mangoni, A. J. Nat. Prod. 2006, 69, 73-78. 
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to the fact that most chiral catalysts depend on heteroatom functionality for substrate 
recognition and differentiation.62  
Asymmetric hydrogenation has shown promise in preparing optically active aliphatic 
substrates.  One of the first examples in this area is the work done by Buchwald in the 
hydrogenation of “largely unfunctionalized” substrates.63  Although these early examples 
deal with substrates containing aromatic substituents, they still provide groundbreaking 
advances in asymmetric synthesis.  In this work, a titanocene pre-catalyst is utilized to 
achieve high levels of enantioselectivity in the hydrogenation of tri-substituted olefins 
(Scheme 26).64 
Scheme 26: Enantioselective hydrogenation of trisubstituted olefins
TiX X
X2=1,1'-binaphth-2,2'-diolate
1.n-buLi/0 oC
1 atm H2
2. PhSiH3
active catalyst
Me Me
91 % yield
>99 % ee
5 mol % cat.
H2 (2000 psig)
65 oC
89 90
 
 Recently, Pfaltz et al. reported the ability of an iridium metal complex to perform 
asymmetric hydrogenations on olefins devoid of heteroatoms. This represents a major 
                                                
62 Willis M. Science, 2006, 311, 619-620. 
63 Xiuhua, C.; Burgess, K. Chem. Rev. 2005, 105, 3272-3296. 
64 Broene, R. D.; Buchwald, S. L. J. Am. Chem. Soc. 1993, 115, 12569-12570. 
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achievement as the first example of a successful enantioselective hydrogenation of a truly 
unfunctionalized substrate, as demonstrated in the hydrogenation of γ-tocotrienyl acetate 
(91), a main component of vitamin E (Scheme 27).65  With the optimized catalyst, great 
enantio- and diastereoselectivity was observed, giving the product in >98% optical purity 
with >99% conversion.  This catalytic system provides a method for installing two 
stereocenters in one step, as opposed to the multi-step methods previously required for the 
preparation of vitamin E analogs.  
Scheme 27: Asymmetric hydrogenation of unfunctionalized olefins
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3.4 Initial Results for the Kinetic Resolution of 2-Pentanol (93) 
Expanding on the limited success observed with β-turn-containing peptides in the 
kinetic resolution of 2-butanol (krel=4.0)66 a selection of β-turn peptides were screened in the 
kinetic resolution of 2-pentanol.  Coupling the success of pentameric peptides in the 
desymmetrization of glycerol (61) and 2-hydroxymethyl cyclopent-2-enone (76), focus was 
concentrated on pentameric peptides.  For the initial screen, 8 pentameric peptides with either 
                                                
65 Bell, S.; Wustenberg, B.; Kaiser, S.; Menges, F.; Netscher, T.; Pfaltz, A. Science, 2006, 
311, 642-644. 
66 (a) Copeland, G. T.; Miller, S. J. J. Am. Chem. Soc. 2001, 123, 6496-6502. (b) Blank, J. T.; 
Guerin, D. J. Miller, S. J. Org. Lett. 2000, 2, 1247-1249. 
Chapter 3 
 
 
59 
D-proline or D-pipecolinic acid in the i+1 position were screened.  The reaction was 
conducted at room temperature with one equivalent of Hunig’s base and 5 mol % catalyst in 
methylene chloride (Scheme 28, Table 5). 
OH OHOAc
Ac2O
Hunigs base
CH2Cl2
5 mol % peptide
Scheme 28: Kinetic Resolution of 2-pentanol (93)
93 94  
entry Peptide Conversion* ee*
1
2
3
4
5
6
7
8
9
PMH-ProD-HPhe-Phe-PheD
PMH-ProD-Ile-Phe-PheD
PMH-ProD-Val-Phe-PheD
PMH-PipD-Aib-Trp(Boc)-PheD
PMH-PipD-Asn(Trt)-Phe-PheD
PMH-PipD-Cha-Phe-PheD
PMH-PipD-HPhe-Phe-PheD
PMH-Thr(tBu)-ValD-His(trt)-PheD-ValD-Thr(tBu)-Ile
PMH-PipD-Sp6-Phe-PheD
20
12
8
6
18
13
14
7
10
40
24
19
10
50
15
29
-15
14
*Crude conversions and ee's of the product were determined by chiral gas chromatography
**Reactions run at -50 oC with 0.4 eq of Ac2O, 1 eq of base and 5 mol% catalyst
Table 5: Initial Screen in the Kinetic resolution of 2-pentanol (93)
 
 
3.5 Conclusion 
Initial results in the kinetic resolution of 2-pentanol (93) indicate the potential for 
peptides to perform kinetic resolutions on aliphatic alcohols.   As observed in this screen, 
conversion for the reaction was low, indicating lower reactivity for secondary alcohols.  
Further optimization of the reaction through increasing the temperature or time of the 
reaction is necessary for increasing the efficiency of the reaction. The volatility of both the 
starting material and product is also problematic in determining accurately the conversion and 
enantioselectivity of each catalyst. Drawing on some of the previous work with the peptides, 
it was also hypothesized that less polar solvents would help to provide a more rigid secondary 
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structure of the peptide, thus leading to higher enantioselectivites.  With this in mind, the next 
step for the optimization of these reaction conditions would be to investigate the selectivity 
and reactivity in a variety of solvents such as ether, pentane, or hexane. 
After reaction conditions are optimized, a logical step for this project would be a 
screen involving a variety of octameric peptides containing a β-turn secondary structure.  
Along with this screen, it would be interesting to see if a pentameric peptide could be 
optimized to give good selectivity as well.  Interestingly, the initial data for this project looks 
promising and lends itself to the possibility of finding effective catalyst, that could be used 
for the kinetic resolution of aliphatic alcohols. 
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3.6 Experimental 
Typical procedure for the acylation of 2-pentanol (93) 
  2-Pentanol (93) was dissolved in CH2Cl2 and Hünig’s base, DMAP, and 
acetic anhydride are added.  The reaction was stirred at r.t. and monitored by 
GC.  Upon completion, the reaction was run through a plug of silica gel and eluted with ethyl 
ether.  Analysis of the product was done using chiral GC. 1 H NMR (CDCl3, 400 MHz) δ 
4.92 (m, 1 H), 2.03 (s, 3 H), 1.57 (m, 1 H), 1.44 (m, 3 H), 1.21 (d, J=6.4 Hz, 3 H), 0.91 (m, 3 
H) ppm; 13C  NMR (CDCl3, 100 MHz) δ 170.7, 71.0, 38.4, 21.7, 20.3, 19.0, 14.3 ppm. 
 
OAc
